Selective Inhibition of Bruton’s Tyrosine Kinase by a Designed Covalent Ligand Leads to Potent Therapeutic Efficacy in Blood Cancers Relative to Clinically Used Inhibitors
Bárbara B. Sousa(University of Lisbon), Gonçalo J. L. Bernardes(Instituto de Medicina Molecular João Lobo Antunes)
Cited by 9
Related Papers
Inverse electron demand Diels–Alder reactions in chemical biology
|Chemical Society Reviews|2017|1.1k
METTL1-mediated m7G modification of Arg-TCT tRNA drives oncogenic transformation
|Molecular Cell|2021|359
Sustainable Polysulfides for Oil Spill Remediation: Repurposing Industrial Waste for Environmental Benefit
|Advanced Sustainable Systems|2018|168
Chemical and Enzymatic Methods for Post-Translational Protein–Protein Conjugation
|Journal of the American Chemical Society|2022|77
Platform for Orthogonal <i>N</i>-Cysteine-Specific Protein Modification Enabled by Cyclopropenone Reagents
|Journal of the American Chemical Society|2022|69